About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Portland | 279 Studies

Clinical Trials Prostate CancerPortland

Prostate Cancer Clinical Trials in Portland

Find 279 clinical trials for prostate cancer near Portland, Oregon. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 201-220 of 279 trials

CompletedVaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRationale: Vaccines may make the body build an immune response to kill tumor cells. It is not yet known if vaccine therapy is effective for prostate cancer.NCT00005947·Duarte, California and 33 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingImpact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceThe impact of fluciclovine (18F) PET on the management of participants with prostate cancer following negative or equivocal PSMA PET Imaging at the time of biochemical recurrenceNCT07569926·San Diego, California and 5 others

CompletedHormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00005044·Birmingham, Alabama and 260 others

Active not recruitingA Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 InactivationThe primary objective is to assess the activity and efficacy of pembrolizumab, a checkpoint inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC)…NCT04104893·San Francisco, California and 12 others

RecruitingInternet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVEThis clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate…NCT06011499·Portland, Oregon

TerminatedStudy of HPN424 in Patients With Advanced Prostate CancerAn open-label, Phase 1/2a, study of HPN424 as monotherapy to assess the safety, tolerability and PK in patients with advanced prostate cancer refractory to androgen therapyNCT03577028·Los Angeles, California and 14 others

CompletedHormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT01546987·Birmingham, Alabama and 171 others

CompletedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer.NCT00002602·Birmingham, Alabama and 227 others

Active not recruitingNational Cancer Institute "Cancer Moonshot Biobank"This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study.NCT04314401·Daphne, Alabama and 149 others

CompletedCombination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00017563·Portland, Oregon and 1 other

CompletedSafety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPCThis is an open-label, multicenter Phase I/II study to evaluate the safety and efficacy of AT-101 in combination with docetaxel and prednisone in men with hormone-refractory…NCT00286793·Hot Springs, Arkansas and 12 others

CompletedExternal-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells.NCT00006365·Birmingham, Alabama and 253 others

RecruitingCarboplatin or Olaparib for BRcA Deficient Prostate CancerThis is an unblinded, randomized clinical study comparing the efficacy of DNA damaging chemotherapy using carboplatin, to standard of care therapy for patients who have metastatic…NCT04038502·West Los Angeles, California and 17 others

Completed3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical ProstatectomyIn April 2011, the United States Food and Drug Administration (FDA) approved the oral drug abiraterone acetate (Zytiga ®) in combination with prednisone (a steroid) to treat…NCT01751451·Chicago, Illinois and 15 others

CompletedOpen Label Prostate Cancer StudyThe main purpose of the study is to investigate the safety and tolerability of AZD3514 when given orally to patients with castration-resistant prostate cancer (CRPC)NCT01162395·Portland, Oregon and 4 others

CompletedStatin Therapy Versus Placebo Prior to ProstatectomyThis is a randomized trial comparing the effect of oral simvastatin versus placebo on targets of the mevalonate pathway in men undergoing a prostatectomy as planned management for…NCT00572468·Durham, North Carolina and 1 other

CompletedObservational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerThis is a single-arm observational longitudinal study in of patients with metastatic castrate-resistant prostate cancer designed to assess the longitudinal trajectory of pain and…NCT02008058·Baltimore, Maryland and 3 others

CompletedA Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerThis is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.NCT03009981·Phoenix, Arizona and 68 others

CompletedComparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate CancerThis Phase 3 study has been designed to confirm that adding custirsen to cabazitaxel/prednisone treatment can slow tumor progression and enhance survival outcomes compared to…NCT01578655·Marina del Rey, California and 93 others

CompletedRandomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate CancerThe purpose of this study is to determine whether survival can be prolonged in patients with castration-resistant prostate cancer who receive dasatinib with docetaxel and…NCT00744497·Mobile, Alabama and 185 others

PreviousPage 11 of 14Next

Other Conditions in Portland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma